[View original text]
Entered the cervical cancer screening market in Uzbekistan
AIDOT, an artificial intelligence medical company, has started exporting a cervical cancer artificial intelligence screening system to Uzbekistan.
On 20th of May, AIDOT announced that it had signed a business partnership agreement with Uzbekistan's GSG Group through the '2022 ICT BUSINESS PARTNERSHIP' hosted by the
National IT Industry Promotion Agency (NIPA) in Uzbekistan.
On this day, not only high-ranking officials from the Ministry of Health of Uzbekistan, but also officials from the Korean Embassy in Uzbekistan attended the event.
This contract, which can screen up to 3.5 million people a year, aims to conduct cervical cancer screening for women aged 30 to 55 in Uzbekistan through the Ministry of Health of
Uzbekistan with AIDOT's Cerviray system.
An official from AIDOT said, "The successful entry of Uzbekistan is of great significance in establishing a bridgehead to advance into the neighboring Commonwealth of Independent
States (CIS) countries, so we will further accelerate the advancement of Korea's excellent solutions to correct the medical imbalance around the world."
AIDOT CEO Jae-hoon Jeong emphasized, “Starting with Uzbekistan, we plan to start exporting to the Philippines and Indonesia in earnest.”
25th. May. 2022. / Korea Economic Daily / Reporter Jae-joon Yang
Comments can be added by Member only